|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/497 | (2013.01) |
| C07D 263/58 | (2006.01) | ||
| C07D 401/12 | (2006.01) | ||
| C07D 263/58 | (2013.01) | ||
| C07D 417/12 | (2006.01) | ||
| C07D 401/12 | (2013.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 417/12 | (2013.01) | ||
| C07F 9/6558 | (2006.01) | ||
| C07D 471/04 | (2013.01) | ||
| C07D 215/227 | (2006.01) | ||
| C07F 9/65583 | (2013.01) | ||
| A61K 31/497 | (2006.01) | ||
| C07D 215/227 | (2013.01) | ||
| C07D 401/14 | (2013.01) | ||
| C07D 413/10 | (2013.01) | ||
| C07D 413/14 | (2013.01) | ||
| C07D 417/14 | (2013.01) | ||
| A61K 31/496 | (2013.01) | ||
| C07D 241/04 | (2013.01) | ||
| C07D 215/22 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 25/18 | (2018.01) | ||
| A61P 25/20 | (2018.01) | ||
| A61P 25/22 | (2018.01) | ||
| A61P 25/24 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Patento numeris | 3309151 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17176623.1 |
| Europos patento paraiškos padavimo data | 2010-06-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-03-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 220480 P | 2009-06-25 | US | |
| 293087 P | 2010-01-07 | US |
| (72) |
REMENAR, Julius F. , US
BLUMBERG, Laura Cook , US
ZEIDAN, Tarek A. , US
|
| (73) |
Alkermes Pharma Ireland Limited ,
Connaught House
1 Burlington Road, Dublin 4,
IE
|
| (54) | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS |
| HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS |